Evidence map›Paper›PMID 36641565›Full record

ReviewFrontiers of optoelectronics2020

Multifunctional layered black phosphorene-based nanoplatform for disease diagnosis and treatment: a review.

Xiazi Huang, Yingying Zhou, Chi Man Woo, Yue Pan, Liming Nie, Puxiang Lai

Abstract readReview
In one paragraph

Review in Frontiers of optoelectronics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Study on the Mechanism of Black Phosphorus Nanosheets Loading SrInternational journal of nanomedicine · 2025
    Article
  2. Recent progress of in-fiber WGM microsphere resonator.Frontiers of optoelectronics · 2023
    Review
  3. Review
  4. Review
  5. Review
  6. Preface to the special issue on "Biomedical Optics".Frontiers of optoelectronics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiazi Huang *Department of Biomedical Engineering, Hong Kong Polytechnic University, Hong Kong, China.
Yingying Zhou *Department of Biomedical Engineering, Hong Kong Polytechnic University, Hong Kong, China.
Chi Man WooDepartment of Biomedical Engineering, Hong Kong Polytechnic University, Hong Kong, China.
Yue PanGuangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
Liming NieState Key Laboratory of Molecular Vaccinology and Molecular Diagnosis & Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.
Puxiang LaiDepartment of Biomedical Engineering, Hong Kong Polytechnic University, Hong Kong, China. puxiang.lai@polyu.edu.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As an outstanding two-dimensional material, black phosphorene, has attracted significant attention in the biomedicine field due to its large surface area, strong optical absorption, distinct bioactivity, excellent biocompatibility, and high biodegradability. In this review, the preparation and properties of black phosphorene are summarized first. Thereafter, black phosphorene-based multifunctional platforms employed for the diagnosis and treatment of diseases, including cancer, bone injuries, brain diseases, progressive oxidative diseases, and kidney injury, are reviewed in detail. This review provides a better understanding of the exciting properties of black phosphorene, such as its high drug-loading efficiency, photothermal conversion capability, high

Indexed as

bioimagingblack phosphorus (BP)bone regenerationcancer therapydelivery nanoplatform

Identifiers

PMID36641565
PMCPMC9743864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.